Randall Kaye, Senior VP, Chief Medical Officer at AVANIR PHARMACEUTICALS (AVNR), bought 5,000 shares at $0.43 ($2K) on 2009-02-23, disclosed to the SEC on 2009-02-25.
Open-market purchase of $2k AVNR by Senior VP, Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| LBPH | BUY | 2024-08-13 | $2K | — | Filing → |
| LBPH | SELL | 2024-08-13 | $1.2M | — | Filing → |
| AXSM | BUY | 2015-12-24 | $9K | — | Filing → |